A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02)
Clinical trial NCT06382129 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06382129
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2026-12-01
- Enrollment
- 698
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.